Clinical Trial Update: Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating aerosolized sargramostim for metastatic melanoma to the lung is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• sargramostim (sargramostim)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Melanoma (Skin), Metastatic Cancer | Phase 2 | Status: COMPLETED